Company Icosavax, Inc.
Equities
ICVX
US45114M1099
Biotechnology & Medical Research
Business Summary
Number of employees: 60
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Russo
DFI | Director of Finance/CFO | 52 | 31/05/21 |
Jennifer Raymond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 64 | 31/08/18 | |
Douglas Holtzman
CTO | Chief Tech/Sci/R&D Officer | 60 | 31/07/19 |
Lori Stewart
HRO | Human Resources Officer | - | - |
Cassia Cearley
PRN | Corporate Officer/Principal | 42 | 30/11/19 |
Ami Shah Brown
LAW | General Counsel | - | - |
General Counsel | 54 | 09/09/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,090,341 | 48,755,518 ( 97.34 %) | 0 | 97.34 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |